Quarterly Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7555731

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
13,240,000,000 JPY
17,387,000,000 JPY
Interest and dividends received
439,000,000 JPY
397,000,000 JPY
Interest paid
-17,000,000 JPY
-17,000,000 JPY
Net cash provided by (used in) operating activities
9,253,000,000 JPY
13,336,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,987,000,000 JPY
-2,986,000,000 JPY
Proceeds from sale of property, plant and equipment
12,000,000 JPY
704,000,000 JPY
Purchase of investment securities
-200,000,000 JPY
JPY
Proceeds from sale of investment securities
5,000,000 JPY
5,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-4,975,000,000 JPY
Other, net
-237,000,000 JPY
-365,000,000 JPY
Net cash provided by (used in) investing activities
-2,627,000,000 JPY
-7,888,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,649,000,000 JPY
-5,714,000,000 JPY
Net cash provided by (used in) financing activities
-6,990,000,000 JPY
-8,129,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-364,000,000 JPY
-2,680,000,000 JPY
Cash and cash equivalents
74,260,000,000 JPY
74,625,000,000 JPY
77,305,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.